Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ethem, Tankurt"'
Autor:
Yusuf Hakan Abacioglu, Ayça Arzu Sayıner, Ömer Topalak, Ethem Tankurt, Mesut Akarsu, Aylin Sengonul, Hale Akpinar
Publikováno v:
Journal of Gastroenterology and Hepatology. 21:1783-1788
Introduction: Mutations of hepatitis B virus (HBV) polymerase, especially occurring at the highly conserved YMDD region, are related to resistance to lamivudine. Although these mutations are frequently secondary to lamivudine use, they can also occur
Publikováno v:
Przegla̜d Gastroenterologiczny
WOS: 000216170900006
PubMed ID: 26516382
Introduction: Helicobacter pylori (H. pylori) occurs throughout the world and causes gastroduodenal diseases. There is data indicating a change in the prevalence of H. pylori infection worldwide. The
PubMed ID: 26516382
Introduction: Helicobacter pylori (H. pylori) occurs throughout the world and causes gastroduodenal diseases. There is data indicating a change in the prevalence of H. pylori infection worldwide. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7866e8c871530866e662bfc8a1cad0e1
https://avesis.deu.edu.tr/publication/details/8bd1a8ef-c317-4cb8-9bad-c9f0496d05ba/oai
https://avesis.deu.edu.tr/publication/details/8bd1a8ef-c317-4cb8-9bad-c9f0496d05ba/oai
Autor:
Abdullah Okan, Emel Altekin, Ömür Gönen, Ibrahim Astarcioglu, Huseyin Astarcioglu, Ethem Tankurt, Ozgul Sagol
Publikováno v:
Digestive Diseases and Sciences. 47:2389-2397
Ursodeoxycholic acid (UDCA) has been shown to have hepatoprotective effects in various liver diseases. This drug has also been found to be effective in patients with nonalcoholic steatohepatitis, improving hepatic steatosis (HS) significantly. The ai
Autor:
S. Colakoglu, Hülya Çetinkaya, Atilla Ökten, Ethem Tankurt, Nurdan Tözün, Halil Degertekin, Hikmet Akkiz, Mustafa Sarioglu, Tülin Şahin, Seren Ozenirler, Hakan Bozkaya, Cihan Yurdaydin, Ozden Uzunalimoglu
Publikováno v:
Digestive Diseases and Sciences. 46:1022-1028
The contribution of hepatitis B, hepatitis C, and excess alcohol intake to the development of hepatocellular carcinoma in Turkey was assessed. The study was conducted through a questionnaire sent to seven major medical referral centers in different r
Autor:
Sedat Karademir, Ahmet Coker, Ibrahim Astarcioglu, Selman Sökmen, Hale Akpinar, Koray Atila, Ethem Tankurt, Huseyin Astarcioglu
Publikováno v:
Journal of Hepato-Biliary-Pancreatic Surgery. 7:72-77
Mirizzi's syndrome is a rare complication of long-standing cholelithiasis. Many surgical approaches of varying complexity have been advocated for treatment. However, the distorted extrahepatic biliary anatomy continues to be threatening, with a high
Publikováno v:
Rheumatology. 36:1005-1008
About a quarter of familial Mediterranean fever (FMF) patients have recurrent painful attacks of polyserositis despite regular colchicine treatment. There is no known alternative drug for colchicine-resistant cases. We had previously observed a patie
Publikováno v:
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology. 22(3)
Publikováno v:
Experimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 117(3)
Cinacalcet is a type II calcimimetic agent which is an allosteric modulator of the calcium-sensing receptor (CaR) located on the surface of the parathyroid cells. Cinacalcet increases the sensitivity of CaR via binding to the transmembrane region of
Autor:
Mehmet Ali Özcan, Serkan Yener, Firat Bayraktar, Baris Akinci, Tevfik Demir, Sena Yesil, Ozgul Sagol, Mesut Akarsu, Ethem Tankurt
Publikováno v:
Journal of endocrinological investigation. 30(10)
Aim: This study was conducted to demonstrate the plasminogen activator inhibitor-1 (PAI-1) and thrombin activatable fibrinolysis inhibitor antigen (TAFI-Ag) levels in non-alcoholic steatohepatitis (NASH). Materials and methods: Twenty-seven patients
Autor:
Dilek Oguz, Atilla Ökten, Selim Gürel, Gürden Gür, Ethem Tankurt, Cem Kalayci, Sabahattin Kaymakoglu, Sule Poturoglu, Galip Ersoz, Yilmaz Cakaloglu, Seren Ozenirler
WOS: 000248523700056
PubMed ID: 17517832
Forty-eight hepatitis B virus (HBV) E antigen-negative chronic hepatitis B patients received pegylated interferon alfa-2b either alone or with lamivudine for 48 weeks and were followed for an additio
PubMed ID: 17517832
Forty-eight hepatitis B virus (HBV) E antigen-negative chronic hepatitis B patients received pegylated interferon alfa-2b either alone or with lamivudine for 48 weeks and were followed for an additio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::912ca6bc6f7c01d528179eab257feb92
https://avesis.gazi.edu.tr/publication/details/3552f795-5156-4304-88aa-f69628549555/oai
https://avesis.gazi.edu.tr/publication/details/3552f795-5156-4304-88aa-f69628549555/oai